Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00898 |
| Species: | Homo sapiens |
| Position : | chr2:65633710-65634058 |
| Year: | 2023 |
| Title: | Enhancer variants on chromosome 2p14 regulating SPRED2 and ACTR2 act as a signal amplifier to protect against rheumatoid arthritis. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | rheumatoid arthritis |
| PMID: | 36924774 |
| MONDO: | MONDO:0008383 |
| Tissue: | pericardium |
| Tissue Ontology ID: | UBERON:0002407 |
| Cell Source: | MH7A |
| CVCL ID: | CVCL_0427 |
| Cell Type: | synovial fibroblast |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | Hi-C; ATAC-seq; ChIP-seq |
| Low Throughput Method: | CRISPR knockout; Luciferase Reporter Assay; RT-RT-qPCR; Western blot |
| Target gene : | SPRED2 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|